178 related articles for article (PubMed ID: 38683136)
21. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract][Full Text] [Related]
22. Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2.
Ni L; Sun P; Ai M; Kong L; Xu R; Li J
Phytomedicine; 2022 Sep; 104():154303. PubMed ID: 35802997
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced Nur77 activates PI3K/Akt signaling
Shi Z; To SKY; Zhang S; Deng S; Artemenko M; Zhang M; Tang J; Zeng JZ; Wong AST
Theranostics; 2021; 11(7):3376-3391. PubMed ID: 33537093
[No Abstract] [Full Text] [Related]
24. Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis.
Jiang S; Li Q; Liu Y; Zhang H; Wang Q; Chen Y; Shi X; Li J; Zhang H; Zhang Y; Xia D; Wu M; Lin J; Zhang C; Pang S; Jiang J; Wen Y; Zhang P
BMC Cancer; 2021 Feb; 21(1):180. PubMed ID: 33607955
[TBL] [Abstract][Full Text] [Related]
25. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
Zhang S; Fan W; He D
J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
[TBL] [Abstract][Full Text] [Related]
26. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
Li Q; Xiao X; Feng J; Yan R; Xi J
Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.
Zou J; Luo H; Zeng Q; Dong Z; Wu D; Liu L
J Transl Med; 2011 Jun; 9():97. PubMed ID: 21702981
[TBL] [Abstract][Full Text] [Related]
28. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
[TBL] [Abstract][Full Text] [Related]
29. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
30. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells.
Jiang ZY; Ma XM; Luan XH; Liuyang ZY; Hong YY; Dai Y; Dong QH; Wang GY
World J Gastroenterol; 2023 Jun; 29(23):3606-3621. PubMed ID: 37398890
[TBL] [Abstract][Full Text] [Related]
31. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
32. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
[TBL] [Abstract][Full Text] [Related]
33. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M; Bouznad N; Hermeking H
Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
[TBL] [Abstract][Full Text] [Related]
34. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
35. PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.
Steller EJ; Raats DA; Koster J; Rutten B; Govaert KM; Emmink BL; Snoeren N; van Hooff SR; Holstege FC; Maas C; Borel Rinkes IH; Kranenburg O
Neoplasia; 2013 Feb; 15(2):204-17. PubMed ID: 23441134
[TBL] [Abstract][Full Text] [Related]
36. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
37. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
39. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
[TBL] [Abstract][Full Text] [Related]
40. SPOCK1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion.
Liu Y; Han T; Wu J; Zhou J; Guo J; Miao R; Xu Z; Xing Y; Bai Y; Hu D
J Transl Med; 2023 Dec; 21(1):909. PubMed ID: 38087364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
